News

30/03/2023
Bioengineering a Vascularized Endocrine pancreas in laboratory for Type 1 Diabetes
A team of researchers at IRCCS Ospedale San Raffaele described, for the first time, an innovative bioengineering approach to develop a Vascularized Endocrine Pancreas for the treatment of type 1 diabetes.
MORE
01/02/2023
The prestigious Consolidator Grant of the European Research Council awarded to Renato Ostuni
Today, the European Research Council (ERC) awarded the Consolidator Grants, Europe's most sought after research funding for scientists at a mid-career stage. Renato Ostuni - Head of the Genomics of the innate immune system Unit at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) and Associate Professor of Histology at the Vita-Salute San Raffaele University – just won one worth 2 million euros for 5 years.
MORE
17/01/2023
MULTIPLE SCLEROSIS: NATURE MEDICINE PUBLISHES THE RESULTS OF THE FIRST CLINICAL TRIAL IN THE WORLD WITH NEURAL STEM CELLS
MULTIPLE SCLEROSIS: NATURE MEDICINE PUBLISHES THE RESULTS OF THE FIRST CLINICAL TRIAL IN THE WORLD WITH NEURAL STEM CELLS

A clinical trial developed and carried out by the IRCCS San Raffaele Scientific Institute opens the way for the development of innovative cellular therapy for patients with progressive forms of multiple sclerosis
MORE
10/11/2022
EDIT project: Early Diagnosis and Therapy of Bladder tumors
Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of bladder cancer
MORE